RE:RE:NRmicrocaphobby wrote: It would appear the Beacon analyst was not aware of the new equipment purchases. I expect he will issue updated guidance once he talks with management and runs his numbers. I wonder if this equipment wil will be for the Ag product. It is a higher margin (double the margin).
From the Cantech report, it makes no sense to increase capacity without believing there will be a much more significant increase in revenues. Maybe it's for the Advaseal line?
"
“On the organic front, the company will look to bolster its extrusion capabilities by adding 5–7-layer extruder and/or increase its conversion capacity. IFX is also considering adding such capabilities through M&A but will remain disciplined on valuation. In terms of leverage, the company sits comfortably with net-debt to EBITDA ratio of just 0.1x (vs. large- cap peers at 3.0x on average),” Shaath wrote."